Clinical trial
Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis
NCT03586557 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 1, 2018
- Completion date
- December 31, 2021
- Enrollment
- 142 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.